In 2017, UC San Francisco received more biomedical research funding from the National Institutes of Health (NIH) than any other public institution, continuing a seven-year trend, according to annual figures from the NIH. In addition, UCSF was the second-highest grant recipient among all public and private institutions nationwide.
SF’s Schools of Medicine and Pharmacy ranked first among their peers nationwide in NIH funding for their biomedical research and graduate-level training, while the Schools of Dentistry and Nursing ranked second in their fields.
Overall, researchers in the University’s four schools of Dentistry, Medicine, Nursing, and Pharmacy, the majority of whom are also affiliated with the UCSF Graduate Division’s doctoral and postdoctoral training programs, were awarded $593.9 million in NIH grants and research contracts in 2017, comprising a 2.8 percent increase over 2016.
These highly competitive funds enable UCSF scientists to pursue research aimed at advancing understanding of human health and disease, and developing new therapies for neurological diseases, cancer, diabetes, cardiovascular disease, and a host of other conditions.
“UCSF is honored to once again be among the nation’s leading recipients of these competitive grants. As a public institution, it is our privilege to pursue research that improves the health of all Americans,” said UCSF Chancellor Sam Hawgood, MBBS. “These funds empower our researchers, students, and trainees to be transformative leaders in their fields, driven by their curiosity to decode the fundamental principles of life and their passion for leveraging those basic discoveries to advance patient care and health equity.”